In their study, flow cytometry was performed and demonstrated that GRP78 is expressed on the cell surface of more than half of primary AML samples using an antibody for ER retention sequence (KDEL) and a biotin-conjugated peptide, but the antibody used in the study is no longer supplied by the company. This evidence concerns the gene HSPA5 and acute myeloid leukemia.